Abstract
Aim:
To investigate the effects of onychin on the proliferation of cultured rat artery vascular smooth muscle cells (VSMCs) in the presence of 10% new-born calf serum (NCS).
Methods:
Rat VSMCs were incubated with onychin 1–50 μmol/L or genistein 10 μmol/L in the presence of 10% NCS for 24 h. The proliferation of VSMCs was measured by cell counting and MTS/PMS colorimetric assays. Cell cycle progression was evaluated by flow cytometry. Retinoblastoma (Rb) phosphorylation, and expression of cyclin D1 and cyclin E were measured by Western blot assays. The tyrosine phosphorylation of ERK1/2 was examined by immunoprecipitation techniques using anti-phospho-tyrosine antibodies.
Results:
The proliferation of VSMCs was accelerated significantly in the presence of 10% NCS. Onychin reduced the metabolic rate of MTS and the cell number of VSMCs in the presence of 10% NCS in a dose-dependent manner. Flow cytometry analysis revealed that the G1-phase fraction ratio in the onychin group was higher than that in the 10% NCS group (85.2% vs 70.0%, P < 0.01), while the S-phase fraction ratio in the onychin group was lower than that in 10% NCS group (4.3% vs 16.4%, P < 0.01). Western blot analysis showed that onychin inhibited Rb phosphorylation and reduced the expression of cyclin D1 and cyclin E. The effects of onychin on proliferation, the cell cycle and the expression of cyclins in VSMCs were similar to those of genistein, an inhibitor of tyrosine kinase. Furthermore immunoprecipitation studies showed that both onychin and genistein markedly inhibited the tyrosine phosphorylation of ERK1/2 induced by 10% NCS.
Conclusion:
Onychin inhibits the proliferation of VSMCs through G1 phase cell cycle arrest by decreasing the tyrosine phosphorylation of ERK1/2, and the expression of cyclin D1 and cyclin E, and sequentially inhibiting Rb phosphorylation.
Similar content being viewed by others
Article PDF
References
Lin MW, Roubin GS, King SB III . Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia. Circulation 1989; 79: 1374–87.
Ohlstein EH, Douglas SA, Sung CP, Yue T, Louden C, Arleth A, et al. Carvedilol, a cardiovascular drug, prevents vascular smooth muscle cell proliferation, migration, and neointimal formation following vascular injury. Proc Natl Acad Sci USA 1993; 93: 6189–93.
Corsini A, Bernini F, Quarato P, Donetti E, Bellosta S, Fumagalli R, et al. Non-lipid-related effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Cardiology 1996; 87: 458–68.
Bennett MR, Anglin S, McEwan JR, Jagoe R, Newby AC, Evan GI . Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxy-nucleotides. J Clin Invest 1994; 93: 820–8.
Pan W, Ikeda K, Takebe M, Yamori Y . Genistein, daidzein and glycitein inhibit growth and DNA synthesis of aortic smooth muscle cells from stroke-prone spontaneously hypertensive rats. J Nutri 2001; 131: 1154–8.
Polkowski K, Mazurek AP . Biological properties of genistein. A review of in vitro and in vivo data. Acta Pol Pharm 2000; 57: 135–55.
Wang HK . The therapeutic potential of flavonoids. Expert Opin Investig Drugs 2000; 9: 2103–19.
Xu YL, Isao K, Ma YB . Acytotoxic flavanone glycoside from onychiun japonicum: structure of onychin. Phytochemistry 1993; 33: 510–1.
Tuo QH, Huang HL, Xie ZZ . Protection of onychin on injury of endothelium-dependent relaxion induced by lysophosphatidylcholine. Chin J Arterioscler 2001; 9: 27–30.
Tuo QH, Liao DF, Zhu BY, Yan FX . Protective effects of onychin on vascular endothelial cell injured by oxidative stress. Chin J Clin Pharmacol Ther 2003; 8: 381–4.
Guo Y, Zhu BY, Yan FX, Liao DF . Protective action of onychin against growth inhibition of endothelial cell injured by oxidation and its mechanism. Chin Pharmacol Bull 2003; 19: 401–3.
Guo Y, Zhu BY, Yan FX, Huang HL, Liao DF . Protective effects of onychin on the human umbilical vein endothelial cell injured by menadione. Chin J Pathophysiol 2003; 19: 10–3.
Tuo QH, Wang C, Yan FX, Liao DF . MAPK pathway mediates the protective effects of onychin on oxidative stress-induced apoptosis in ECV304 endothelial cells. Life Sci 2004; 76: 487–97.
Tu YS, Huang HL, Zhu BY, Liao DF . Enzymatic dispersion method of primary culture of rat aortic vascular smooth muscle cells. Chin J Arterioscler 2001; 9: 438–40.
Liao DF, Monia B, Dean N, Berk BC . Protein kinase C-ζ mediates angiotensin II activation of ERK1/2 in vascular smooth muscle cells. J Biol Chem 1997; 272: 6146–50.
Liao DF, Jin ZG, Baas AS, Daum G, Gygi SP, Aebersold R, et al. Purification and identification of secreted oxidative stress-induced factors from vascular smooth muscle cells. J Biol Chem 2000; 275: 189–96.
Goodrich DW, Lee WH . Molecular characterization of the retinoblastoma susceptibility gene. Biochim Biophys Acta 1993; 1155: 43–61.
Hiebert SW . Regions of the retinoblastoma gene product required for its interaction with the E2F transcription factor are necessary for E2 promoter repression and pRb-mediated growth suppression. Mol Cell Biol 1993; 13: 3384–91.
King KL, Cidlowski JA . Cell cycle regulation and apoptosis. Annu Rev Physiol 1998; 60: 601–17.
Chang MW, Barr E, Seltzer J, Nabel GJ, Nabel GJ, Parmacek MS, et al. Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product. Science 1995; 267: 518–22.
Slansky JE, Farnham PJ . Introduction to the E2F family: protein structure and gene regulation. Curr Top Microbiol Immunol 1996; 208: 1–30.
Sherr CJ . G1 phase progression: cycling on cue. Cell 1994; 79: 551–5.
Lu B, Dai YM . Abnormal cycle regulation of cells in the HCC. World J Gastroenterol 2001; 9: 205–8.
Ishizuka S, Yano T, Hagiwara K, Sone M, Nihei H, Ozasa H, et al. Extracellular signal-regulated kinase mediates renal regeneration in rats with myoglobinuric acute renal injury. Biochem Biophys Res Commun 1999; 254: 88–92.
Kronemann N, Nockher WA, Busse R, Schini-Kerth VB . Growth-inhibitory effect of cyclic GMP- and cyclic AMP-dependent vasodilators on rat vascular smooth muscle cells: effect on cell cycle and cyclin expression. Br J Pharmacol 1999; 126: 349–57.
Seger R, Krebs EG . The MAPK signaling cascade. FASEB J 1995; 9: 726–35.
Huang CY, Ferrell JE Jr . Ultrasensitivity in the mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA 1996; 93: 10078–83.
Author information
Authors and Affiliations
Corresponding author
Additional information
Project supported by grants from the State Key Basic Research and Development Program of China (973: No G2000056905), the National Natural Science Foundation of China (No 39970847, 30171084), and the Natural Science Foundation of Hunan (No 03JJY3037).
Rights and permissions
About this article
Cite this article
Yang, M., Huang, Hl., Zhu, By. et al. Onychin inhibits proliferation of vascular smooth muscle cells by regulating cell cycle. Acta Pharmacol Sin 26, 205–210 (2005). https://doi.org/10.1111/j.1745-7254.2005.00526.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2005.00526.x
Keywords
This article is cited by
-
Ezetimibe suppresses cholesterol accumulation in lipid-loaded vascular smooth muscle cells in vitro via MAPK signaling
Acta Pharmacologica Sinica (2014)
-
Mechanism of induction apoptosis of Onychin in ovarian cells in vitro
The Chinese-German Journal of Clinical Oncology (2013)